Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 Aug 15;294(Pt 1):153–158. doi: 10.1042/bj2940153

Endothelin (ETA) receptor number and calcium signalling are up-regulated by protein kinase C-beta 1 overexpression.

J A Pachter 1, R Mayer-Ezell 1, R M Cleven 1, A B Fawzi 1
PMCID: PMC1134578  PMID: 8363566

Abstract

To evaluate the role of protein kinase C (PKC) in regulation of cellular responsiveness to mitogens, we used rat 6 (R6) fibroblasts that stably overexpress the beta 1 isoenzyme of protein kinase C (PKC-beta 1). The potent vasoconstrictor and mitogen endothelin-1 (ET-1; 100 nM) was substantially more effective in stimulating InsP3 accumulation in PKC-beta 1-overexpressing fibroblasts (PKC3 cells) than in control fibroblasts lacking the PKC-beta 1 cDNA insert. PKC3 cells were found to express a 7-fold greater number of endothelin receptors than did control cells, whereas both cell lines showed equivalent Kd values. These receptors were of the ETA subtype, as defined by a 1000-fold greater affinity for ET-1 than for ET-3. Changes in intracellular free Ca2+ levels ([Ca2+]i) in response to ET-1 measured with the fluorescent Ca2+ indicator fura-2 showed that ET-1 was more potent and efficacious in stimulating [Ca2+]i in PKC3 cells than in control fibroblasts. The ET-1-induced Ca2+ rise was completely blocked by the selective ETA antagonist BQ123, but only slightly diminished by extracellular application of 2 mM EGTA. In contrast with the effects of PKC-beta 1 overexpression on responsiveness to ET-1, alpha-thrombin, which was previously found to have a weaker effect on InsP3 accumulation in PKC-beta 1-overexpressing cells, was also a less effective stimulator of [Ca2+]i in PKC3 cells than in control cells. These results demonstrate that, although the Ca2+ response to alpha-thrombin is diminished by PKC-beta 1 overexpression, ETA receptor number and cellular responsiveness to ET-1 are increased in PKC-beta 1-overexpressing cells.

Full text

PDF
153

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 1990 Dec 20;348(6303):730–732. doi: 10.1038/348730a0. [DOI] [PubMed] [Google Scholar]
  2. Ashendel C. L. The phorbol ester receptor: a phospholipid-regulated protein kinase. Biochim Biophys Acta. 1985 Sep 9;822(2):219–242. doi: 10.1016/0304-4157(85)90009-7. [DOI] [PubMed] [Google Scholar]
  3. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  4. Berridge M. J., Irvine R. F. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature. 1984 Nov 22;312(5992):315–321. doi: 10.1038/312315a0. [DOI] [PubMed] [Google Scholar]
  5. Bishop W. R., Pachter J. A., Pai J. K. Regulation of phospholipid hydrolysis and second messenger formation by protein kinase C. Adv Enzyme Regul. 1992;32:177–192. doi: 10.1016/0065-2571(92)90016-s. [DOI] [PubMed] [Google Scholar]
  6. Cozza E. N., Vila M. C., Gomez-Sanchez C. E. ET-1 receptors in C-6 cells: homologous down-regulation and modulation by protein kinase C. Mol Cell Endocrinol. 1990 Apr 17;70(2):155–164. doi: 10.1016/0303-7207(90)90155-2. [DOI] [PubMed] [Google Scholar]
  7. Doherty A. M. Endothelin: a new challenge. J Med Chem. 1992 May 1;35(9):1493–1508. doi: 10.1021/jm00087a001. [DOI] [PubMed] [Google Scholar]
  8. Eldar H., Zisman Y., Ullrich A., Livneh E. Overexpression of protein kinase C alpha-subtype in Swiss/3T3 fibroblasts causes loss of both high and low affinity receptor numbers for epidermal growth factor. J Biol Chem. 1990 Aug 5;265(22):13290–13296. [PubMed] [Google Scholar]
  9. Exton J. H. Signaling through phosphatidylcholine breakdown. J Biol Chem. 1990 Jan 5;265(1):1–4. [PubMed] [Google Scholar]
  10. Gandhi C. R., Stephenson K., Olson M. S. Endothelin, a potent peptide agonist in the liver. J Biol Chem. 1990 Oct 15;265(29):17432–17435. [PubMed] [Google Scholar]
  11. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  12. Hirata Y., Takagi Y., Fukuda Y., Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis. 1989 Aug;78(2-3):225–228. doi: 10.1016/0021-9150(89)90227-x. [DOI] [PubMed] [Google Scholar]
  13. Hockberger P., Toselli M., Swandulla D., Lux H. D. A diacylglycerol analogue reduces neuronal calcium currents independently of protein kinase C activation. Nature. 1989 Mar 23;338(6213):340–342. doi: 10.1038/338340a0. [DOI] [PubMed] [Google Scholar]
  14. Housey G. M., Johnson M. D., Hsiao W. L., O'Brian C. A., Murphy J. P., Kirschmeier P., Weinstein I. B. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell. 1988 Feb 12;52(3):343–354. doi: 10.1016/s0092-8674(88)80027-8. [DOI] [PubMed] [Google Scholar]
  15. Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., Fukami T., Ishikawa K., Nishikibe M., Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 1992;50(4):247–255. doi: 10.1016/0024-3205(92)90331-i. [DOI] [PubMed] [Google Scholar]
  16. Imai T., Hirata Y., Eguchi S., Kanno K., Ohta K., Emori T., Sakamoto A., Yanagisawa M., Masaki T., Marumo F. Concomitant expression of receptor subtype and isopeptide of endothelin by human adrenal gland. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1115–1121. doi: 10.1016/0006-291x(92)91847-j. [DOI] [PubMed] [Google Scholar]
  17. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Issing W. J., Wustrow T. P. Uberexpression von Proteinkinase-C-Isoenzymen in menschlichen Tumorzellinien. Laryngorhinootologie. 1991 Mar;70(3):146–150. doi: 10.1055/s-2007-998007. [DOI] [PubMed] [Google Scholar]
  19. Kariya K., Karns L. R., Simpson P. C. Expression of a constitutively activated mutant of the beta-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the beta-myosin heavy chain isogene. J Biol Chem. 1991 Jun 5;266(16):10023–10026. [PubMed] [Google Scholar]
  20. Krauss R. S., Housey G. M., Johnson M. D., Weinstein I. B. Disturbances in growth control and gene expression in a C3H/10T1/2 cell line that stably overproduces protein kinase C. Oncogene. 1989 Aug;4(8):991–998. [PubMed] [Google Scholar]
  21. MacCumber M. W., Ross C. A., Snyder S. H. Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2359–2363. doi: 10.1073/pnas.87.6.2359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mattingly R. R., Wasilenko W. J., Woodring P. J., Garrison J. C. Selective amplification of endothelin-stimulated inositol 1,4,5-trisphosphate and calcium signaling by v-src transformation of rat-1 fibroblasts. J Biol Chem. 1992 Apr 15;267(11):7470–7477. [PubMed] [Google Scholar]
  23. Melloni E., Pontremoli S., Viotti P. L., Patrone M., Marks P. A., Rifkind R. A. Differential expression of protein kinase C isozymes and erythroleukemia cell differentiation. J Biol Chem. 1989 Nov 5;264(31):18414–18418. [PubMed] [Google Scholar]
  24. Muldoon L. L., Pribnow D., Rodland K. D., Magun B. E. Endothelin-1 stimulates DNA synthesis and anchorage-independent growth of Rat-1 fibroblasts through a protein kinase C-dependent mechanism. Cell Regul. 1990 Mar;1(4):379–390. doi: 10.1091/mbc.1.4.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986 Jul 18;233(4761):305–312. doi: 10.1126/science.3014651. [DOI] [PubMed] [Google Scholar]
  26. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature. 1988 Aug 25;334(6184):661–665. doi: 10.1038/334661a0. [DOI] [PubMed] [Google Scholar]
  27. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984 Apr 19;308(5961):693–698. doi: 10.1038/308693a0. [DOI] [PubMed] [Google Scholar]
  28. Ohlstein E. H., Arleth A., Bryan H., Elliott J. D., Sung C. P. The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis. Eur J Pharmacol. 1992 Apr 10;225(4):347–350. doi: 10.1016/0922-4106(92)90109-9. [DOI] [PubMed] [Google Scholar]
  29. Osada S., Mizuno K., Saido T. C., Akita Y., Suzuki K., Kuroki T., Ohno S. A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominantly expressed in lung and skin. J Biol Chem. 1990 Dec 25;265(36):22434–22440. [PubMed] [Google Scholar]
  31. Pachter J. A., Law G. J., Dannies P. S. Bombesin stimulates inositol polyphosphate production in GH4C1 pituitary tumor cells: comparison with TRH. Biochem Biophys Res Commun. 1988 Jul 29;154(2):654–659. doi: 10.1016/0006-291x(88)90189-1. [DOI] [PubMed] [Google Scholar]
  32. Pachter J. A., Law G. J., Dannies P. S. Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion. Eur J Pharmacol. 1991 Apr 3;195(3):373–379. doi: 10.1016/0014-2999(91)90478-9. [DOI] [PubMed] [Google Scholar]
  33. Pachter J. A., Pai J. K., Mayer-Ezell R., Petrin J. M., Dobek E., Bishop W. R. Differential regulation of phosphoinositide and phosphatidylcholine hydrolysis by protein kinase C-beta 1 overexpression. Effects on stimulation by alpha-thrombin, guanosine 5'-O-(thiotriphosphate), and calcium. J Biol Chem. 1992 May 15;267(14):9826–9830. [PubMed] [Google Scholar]
  34. Pai J. K., Dobek E. A., Bishop W. R. Endothelin-1 activates phospholipase D and thymidine incorporation in fibroblasts overexpressing protein kinase C beta 1. Cell Regul. 1991 Nov;2(11):897–903. doi: 10.1091/mbc.2.11.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pai J. K., Pachter J. A., Weinstein I. B., Bishop W. R. Overexpression of protein kinase C beta 1 enhances phospholipase D activity and diacylglycerol formation in phorbol ester-stimulated rat fibroblasts. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):598–602. doi: 10.1073/pnas.88.2.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Persons D. A., Wilkison W. O., Bell R. M., Finn O. J. Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA. Cell. 1988 Feb 12;52(3):447–458. doi: 10.1016/s0092-8674(88)80037-0. [DOI] [PubMed] [Google Scholar]
  37. Resink T. J., Scott-Burden T., Weber E., Bühler F. R. Phorbol ester promotes a sustained down-regulation of endothelin receptors and cellular responses to endothelin in human vascular smooth muscle cells. Biochem Biophys Res Commun. 1990 Feb 14;166(3):1213–1219. doi: 10.1016/0006-291x(90)90995-y. [DOI] [PubMed] [Google Scholar]
  38. Roubert P., Gillard V., Plas P., Guillon J. M., Chabrier P. E., Braquet P. Angiotensin II and phorbol-esters potently down-regulate endothelin (ET-1) binding sites in vascular smooth muscle cells. Biochem Biophys Res Commun. 1989 Oct 31;164(2):809–815. doi: 10.1016/0006-291x(89)91531-3. [DOI] [PubMed] [Google Scholar]
  39. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 1990 Dec 20;348(6303):732–735. doi: 10.1038/348732a0. [DOI] [PubMed] [Google Scholar]
  40. Schaffner W., Weissmann C. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal Biochem. 1973 Dec;56(2):502–514. doi: 10.1016/0003-2697(73)90217-0. [DOI] [PubMed] [Google Scholar]
  41. Streb H., Irvine R. F., Berridge M. J., Schulz I. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature. 1983 Nov 3;306(5938):67–69. doi: 10.1038/306067a0. [DOI] [PubMed] [Google Scholar]
  42. Takai Y., Kishimoto A., Kikkawa U., Mori T., Nishizuka Y. Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system. Biochem Biophys Res Commun. 1979 Dec 28;91(4):1218–1224. doi: 10.1016/0006-291x(79)91197-5. [DOI] [PubMed] [Google Scholar]
  43. Takuwa N., Takuwa Y., Yanagisawa M., Yamashita K., Masaki T. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem. 1989 May 15;264(14):7856–7861. [PubMed] [Google Scholar]
  44. Takuwa Y., Kasuya Y., Takuwa N., Kudo M., Yanagisawa M., Goto K., Masaki T., Yamashita K. Endothelin receptor is coupled to phospholipase C via a pertussis toxin-insensitive guanine nucleotide-binding regulatory protein in vascular smooth muscle cells. J Clin Invest. 1990 Mar;85(3):653–658. doi: 10.1172/JCI114488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Weinstein I. B. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture. Cancer Res. 1988 Aug 1;48(15):4135–4143. [PubMed] [Google Scholar]
  46. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES